|
Status
|
Topic selection
|
|
Technology type
|
Medicine
|
|
Decision
|
Not selected
|
|
Reason for decision
|
Not eligible for Health Technology Evaluation guidance
|
|
Further information
|
As per section 4.2.8 of the topic selection manual Generic or biosimilar medicines are not eligible to be considered if the branded version is recommended in NICE technology appraisal or highly specialised technologies guidance (see the European Medicines Agency's definitions of generic medicines and biosimilar medicine). This is because the recommendation usually applies to the generic or biosimilar medicine.
|
| ID number |
11790
|
Project Team
| Project lead |
Danielle Lees |
Email enquiries
For further information on how we select topics for development, please see our page about topic selection